Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling

CNS Neuroscience and Therapeutics

Volumn 20, Issue 2, 2014, Pages 112-118

  Bao, Zhao Shi ^a   Li, Ming Yang ^a   Wang, Jia Yin ^b   Zhang, Chuan Bao ^a   Wang, Hong Jun ^c   Yan, Wei ^a   Liu, Yan Wei ^a   Zhang, Wei ^a   Chen, Ling ^b   Jiang, Tao ^a,d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Gliomas; mRNA; Prognosis; Risk score

Indexed keywords

MESSENGER RNA;

ACCURACY; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE ONTOLOGY; GENE SET VARIATION ANALYSIS; GENE SIGNATURE; GENETIC ANALYSIS; GLIOMA; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STATISTICAL MODEL;

BIOMARKER; GLIOMAS; MRNA; PROGNOSIS; RISK SCORE;

BRAIN NEOPLASMS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VARIATION; GENOMIC LIBRARY; GLIOMA; HISTONE DEACETYLASES; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; KAPLAN-MEIER ESTIMATE; MEMBRANE PROTEINS; METALLOTHIONEIN; MICROARRAY ANALYSIS; MICROTUBULE-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; RAB1 GTP-BINDING PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUBULIN;

EID: 84892548159     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12171     Document Type: Article

References (37)

1. Mischel PS, Cloughesy TF. Targeted molecular therapy of GBM. Brain Pathol 2003;13:52-61.
2. Wang Y, Jiang T. Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer Lett 2013;331:139-146.
3. Zhang W, Zhang J, Yan W, et al. Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme. Cancer 2013;119:814-824.
4. Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010;17:98-110.
5. Lossos IS, Czerwinski DK, Alizadeh AA, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 2004;350:1828-1837.
6. da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
7. Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics 2013;14:7.
8. Wang C, Yoo Y, Fan H, Kim E, Guan KL, Guan JL. Regulation of Integrin beta 1 recycling to lipid rafts by Rab1a to promote cell migration. J Biol Chem 2010;285:29398-29405.
9. Yamamoto H, Ngan CY, Monden M. Cancer cells survive with survivin. Cancer Sci 2008;99:1709-1714.
10. Kanwar JR, Kamalapuram SK, Kanwar RK. Targeting survivin in cancer: patent review. Expert Opin Ther Pat 2010;20:1723-1737.
11. Ryan BM, O'Donovan N, Duffy MJ. Survivin: a new target for anti-cancer therapy. Cancer Treat Rev 2009;35:553-562.
12. Wobser M, Keikavoussi P, Kunzmann V, Weininger M, Andersen MH, Becker JC. Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin. Cancer Immunol Immunother 2006;55:1294-1298.
13. O'Connor DS, Schechner JS, Adida C, et al. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol 2000;156:393-398.
14. Gimenez-Bonafe P, Tortosa A, Perez-Tomas R. Overcoming drug resistance by enhancing apoptosis of tumor cells. Curr Cancer Drug Targets 2009;9:320-340.
15. Andersen MH, Svane IM, Becker JC, Straten PT. The universal character of the tumor-associated antigen survivin. Clin Cancer Res 2007;13:5991-5994.
16. Cheung CH, Cheng L, Chang KY, Chen HH, Chang JY. Investigations of survivin: the past, present and future. Front Biosci (Landmark Ed) 2011;16:952-961.
17. Gupta MP, Amin CS, Gupta M, Hay N, Zak R. Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression. Mol Cell Biol 1997;17:3924-3936.
18. Karasseva N, Tsika G, Ji J, Zhang A, Mao X, Tsika R. Transcription enhancer factor 1 binds multiple muscle MEF2 and A/T-rich elements during fast-to-slow skeletal muscle fiber type transitions. Mol Cell Biol 2003;23:5143-5164.
19. Milewski RC, Chi NC, Li J, Brown C, Lu MM, Epstein JA. Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3. Development 2004;131:829-837.
20. Sawada A, Nishizaki Y, Sato H, et al. Tead proteins activate the Foxa2 enhancer in the node in cooperation with a second factor. Development 2005;132:4719-4729.
21. Gupta M, Kogut P, Davis FJ, Belaguli NS, Schwartz RJ, Gupta MP. Physical interaction between the MADS box of serum response factor and the TEA/ATTS DNA-binding domain of transcription enhancer factor-1. J Biol Chem 2001;276:10413-10422.
22. Lu C, Zhang J, He S, et al. Increased alpha-Tubulin1b expression indicates poor prognosis and resistance to chemotherapy in hepatocellular carcinoma. Dig Dis Sci 2013. [Epub ahead of print].
23. Ryu HH, Jung S, Jung TY, et al. Role of metallothionein 1E in the migration and invasion of human glioma cell lines. Int J Oncol 2012;41:1305-1313.
24. Zheng H, Ji C, Zou X, et al. Molecular cloning and characterization of a novel human putative transmembrane protein homologous to mouse sideroflexin associated with sideroblastic anemia. DNA Seq 2003;14:369-373.
25. Perez de Castro I, Malumbres M. Mitotic stress and chromosomal instability in cancer: the case for TPX2. Genes Cancer 2012;3:721-730.
26. Cernotta N, Clocchiatti A, Florean C, Brancolini C. Ubiquitin-dependent degradation of HDAC4, a new regulator of random cell motility. Mol Biol Cell 2011;22:278-289.
27. Rao V, Al-Weshahy A. Plant-based diets and control of lipids and coronary heart disease risk. Curr Atheroscler Rep 2008;10:478-485.
28. Yan W, Zhang W, You G, et al. Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. Neuro Oncol 2012;14:1432-1440.
29. Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006;9:157-173.
30. Li A, Walling J, Ahn S, et al. Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res 2009;69:2091-2099.
31. Noushmehr H, Weisenberger DJ, Diefes K, et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010;17:510-522.
32. Zhang W, Yan W, You G, et al. Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma. Cancer Lett 2013;328:120-125.
33. Luketich JD, Friedman DM, Weigel TL, et al. Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 1999;68:1133-1136; discussion 1136-7.
34. Kaushik N, Khalid A, Brody D, Luketich J, McGrath K. Endoscopic ultrasound compared with laparoscopy for staging esophageal cancer. Ann Thorac Surg 2007;83:2000-2002.
35. May A, Gunter E, Roth F, et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 2004;53:634-640.
36. Quackenbush J. Microarray analysis and tumor classification. N Engl J Med 2006;354:2463-2472.
37. Shimada Y, Sato F, Shimizu K, Tsujimoto G, Tsukada K. cDNA microarray analysis of esophageal cancer: discoveries and prospects. Gen Thorac Cardiovasc Surg 2009;57:347-356.